MergerLinks - Daniel R. Omstead

Cross BorderAcquisitionPrivate EquityPrivateMinorityVenture Capital

target

VECTIVBIO

bidder

Cormorant Asset Management

£84m

35 dealmakers

France

MinorityAcquisitionCross BorderPrivate EquityPrivateVenture Capital

target

DYNACURE

bidder

Kurma Partners

£41m

8 dealmakers

Cross BorderMinorityAcquisitionPrivatePrivate EquityVenture Capital

Pharmaceuticals

target

OCULIS

bidder

Tekla Capital Management

£40m

18 dealmakers

De-SPACAcquisitionPrivateReverse TakeoverMergerCross Border

target

Moonlake Immunotherapeutics

bidder

Bvf Partners

£169m

44 dealmakers

Private EquityMinorityCross BorderPrivateVenture CapitalAcquisition

target

Hotspot Therapeutics

bidder

Sofinnova Partners

£74m

11 dealmakers

Cross BorderVenture CapitalPrivate EquityMinorityAcquisitionPrivate

target

Endeavor Biomedicines

bidder

Ally Bridge Group

£74m

11 dealmakers

DomesticMinorityPrivate EquityAcquisitionPrivateVenture Capital

Pharmaceuticals

target

INVETX

bidder

F-prime Capital

£49m

13 dealmakers

Reverse TakeoverMajorityMergerAcquisitionPrivateDe-SPACPrivate EquityCross Border

Pharmaceuticals

target

OCULIS

bidder

Tekla Capital Management

£194m

25 dealmakers

France

Venture CapitalAcquisitionCross BorderMinorityPrivatePrivate Equity

target

Amolyt Pharma

bidder

Tekla Capital Management

£115m

18 dealmakers

AcquisitionDomesticPrivate EquityMajorityPrivate

Private Equity

target

Tekla Capital Management (healthcare Fund Management Capabilities)

bidder

Abrdn (ex-standard Life Aberdeen)

value n/a

23 dealmakers